GDP and AGE receptors: Mechanisms of peritoneal damage

Contributions to Nephrology

Volumn 150, Issue , 2006, Pages 77-83

  Schwenger, Vedat ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; GLUCOSE; IMMUNOGLOBULIN RECEPTOR;

ANGIOGENESIS; EPITHELIUM CELL; FIBROSIS; HUMAN; METABOLISM; PATHOLOGY; PERITONEAL DIALYSIS; PERITONEUM; PHYSIOLOGY; REVIEW; VASCULARIZATION;

EPITHELIAL CELLS; FIBROSIS; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PERITONEAL DIALYSIS; PERITONEUM; RECEPTORS, IMMUNOLOGIC;

EID: 33745283639     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000093505     Document Type: Review

References (20)

1. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S: Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997;51:182-186.
2. Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT: The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003;S43-S49.
3. Wieslander AP, Deppisch R, Svensson E, Forsback G, Speidel R, Rippe B: In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995;15:158-164.
4. Wieslander A, Linden T, Musi B, Jarkelid L, Speidel R, Beck W, Henle T, Deppisch R: Exogenous uptake of carbonyl stress compounds promoting AGE formation from peritoneal dialysis fluids. Contrib Nephrol 2001;82-89.
5. Witowski J, Bender TO, Wisniewska-Elnur J, Ksiazek K, Passlick-Deetjen J, Breborowicz A, Jörres A: Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se. Perit Dial Int 2003;23:381-390.
6. Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E: Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003;63:298-305.
7. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A: Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001;12:2434-2441.
8. Jörres A: Effect of peritoneal dialysis on peritoneal cell biology: peritoneal fibroblasts. Perit Dial Int 1999;19(suppl 2):S348-S352.
9. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jörres A: Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000;11:729-739.
10. Morgan LW, Wieslander A, Davies M, Horiuchi T, Ohta Y, Beavis MJ, Craig KJ, Williams JD, Topley N: Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int 2003;64:1854-1866.
11. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sanchez-Madrid F, Lopez-Cabrera M: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003;348:403-413.
12. Ito T, Yorioka N, Yamamoto M, Kataoka K, Yamakido M: Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. J Am Soc Nephrol 2000;11:1969-1979.
13. Leung JC, Chan LY, Li FF, Tang SC, Chan KW, Chan TM, Lam MF, Wieslander A, Lai KN: Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF. Nephrol Dial Transplant 2005;20:1336-1349.
14. Bierhaus A, Humpert PM, Stern DM, Arnold B, Nawroth PP: Advanced glycation end product receptor-mediated cellular dysfunction. Ann NY Acad Sci 2005;1043:676-680.
15. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001;50:2792-2808.
16. Ogata S, Yorioka N, Nishida Y, Shao JC, Yamakida M: Expression of Receptor for Advanced Glycation End Product mRNA by Human Peritoneal Mesothelial Cells. Nephron 2000;86:245-246.
17. Lai KN, Leung JC, Chan LY, Li FF, Tang SC, Lam MF, Tse KC, Yip TP, Chan TM, Wieslander A, Vlassara H: Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products. Clin Exp Immunol 2004;138:466-475.
18. Schwenger V, Morath C, Salava A, Amann K, Seregin Y, Deppisch R, Ritz E, Bierhaus A, Nawroth PP, Zeier M: Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. J Am Soc Nephrol 2006;17:199-207.
19. De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH: Inhibition of the Interaction of AGE-RAGE Prevents Hyperglycemia-Induced Fibrosis of the Peritoneal Membrane. J Am Soc Nephrol 2003;14:2109-2118.
20. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001;108:1853-1863.